4. Takeda and Covance and Quintiles

4. Takeda and Covance and Quintiles:

Finalized in early 2011, Takeda Pharmaceutical Industries' deal with Covance ($CVD) and Quintiles is one that embraces virtual outsourcing when it comes to drug development. According to an Outsourcing-Pharma story, when the partnership was announced Takeda's aim was to implement a "global program-level sourcing strategy" to improve efficacy. With that in mind, the virtual outsourcing partnership provided no fuss for either party: Takeda gained full access to both CROs development and lab services, while Covance and Quintiles were given resources and pipeline access in turn.

While Takeda, Covance and Quintiles are among the biggest and best in their respective fields, the virtual business model can work with smaller CROs and pharma companies without a large working infrastructure.

4. Takeda and Covance and Quintiles

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.